🪴 PG Notes
Search
Search
Dark mode
Light mode
Explorer
concepts
Fluorescein Angiography (FFA)
Intravitreal Injections
Laser Photocoagulation
Nd:YAG Posterior Hyaloidotomy
OCT Interpretation
Pneumatic Displacement of Submacular Hemorrhage
entities
Bevacizumab (Avastin)
Branch Retinal Vein Occlusion (BRVO)
Coats Disease
Diabetic Retinopathy
Hypertensive Retinopathy
Radiation Retinopathy
Ranibizumab (Lucentis)
Retinal Arterial Macroaneurysm (RAM)
Vitreous Hemorrhage
Von Hippel-Lindau Disease (VHL)
quizzes
Quiz — Retinal Arterial Macroaneurysm
sources
Macroaneurysm — EyeWiki
Retina Overview — Topic Map & Knowledge Gaps
Wiki Log
Home
❯
entities
Folder: entities
10 items under this folder.
Apr 14, 2026
Bevacizumab (Avastin)
anti-vegf
pharmacotherapy
bevacizumab
Apr 14, 2026
Branch Retinal Vein Occlusion (BRVO)
vascular-diseases
retinal-vein-occlusion
brvo
Apr 14, 2026
Coats Disease
vascular-diseases
pediatric-retina
coats-disease
Apr 14, 2026
Diabetic Retinopathy
vascular-diseases
diabetic-retinopathy
diabetes
Apr 14, 2026
Hypertensive Retinopathy
hypertensive-retinopathy
systemic-associations
vascular-diseases
Apr 14, 2026
Radiation Retinopathy
systemic-associations
radiation-retinopathy
vascular-diseases
Apr 14, 2026
Ranibizumab (Lucentis)
anti-vegf
pharmacotherapy
ranibizumab
Apr 14, 2026
Retinal Arterial Macroaneurysm (RAM)
retinal-arterial-macroaneurysm
vascular-diseases
hypertension
Apr 14, 2026
Vitreous Hemorrhage
vitreous-hemorrhage
complications
vascular-diseases
Apr 14, 2026
Von Hippel-Lindau Disease (VHL)
tumors
phakomatoses
von-hippel-lindau